AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2013
Feb 12, 2013
30016_dirs_2013-02-12_370ee9a2-c983-4598-aa98-35ccc97e4456.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2013-02-08
Reporting Person: BROWN WILLIAM E III (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-02-08 | Common Stock | M | 22178 | $29.3600 | Acquired | 29437 | Direct |
| 2013-02-08 | Common Stock | S | 22178 | $93.7809 | Disposed | 7259 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-02-08 | Non-Qualified Stock Option (right to buy) | $29.3600 | M | 22178 | Disposed | 2015-12-02 | Common Stock (22178) | Direct |
Footnotes
F1: The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $93.66 to $93.90, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
F2: Grant of options to buy shares of common stock becomes exercisable as to 5,545 shares on 12/03/2009 and 12/03/2010, 5,544 shares on 12/03/2011, 12/03/2012 and 12/03/2013.